Vir Biotechnology, Inc. (NASDAQ:VIR – Get Free Report) gapped up prior to trading on Friday following a better than expected earnings announcement. The stock had previously closed at $9.18, but opened at $10.13. Vir Biotechnology shares last traded at $10.21, with a volume of 527,255 shares. The company reported ($0.48) earnings per share for the […]
Vir Biotechnology (NASDAQ:VIR – Get Free Report) is scheduled to be releasing its earnings data after the market closes on Thursday, May 2nd. Analysts expect Vir Biotechnology to post earnings of ($0.99) per share for the quarter. Persons that wish to register for the company’s earnings conference call can do so using this link. Vir […]
Vir Biotechnology, Inc. (NASDAQ:VIR – Get Free Report) EVP Ann M. Hanly sold 2,711 shares of Vir Biotechnology stock in a transaction that occurred on Monday, April 1st. The shares were sold at an average price of $10.05, for a total value of $27,245.55. Following the sale, the executive vice president now directly owns 132,069 […]
Vir Biotechnology, Inc. (NASDAQ:VIR – Get Free Report) CEO Backer Marianne De sold 72,995 shares of Vir Biotechnology stock in a transaction on Wednesday, April 3rd. The stock was sold at an average price of $9.46, for a total transaction of $690,532.70. Following the sale, the chief executive officer now owns 678,457 shares of the […]
Vir Biotechnology, Inc. (NASDAQ:VIR – Get Free Report) CEO Backer Marianne De sold 72,995 shares of the business’s stock in a transaction that occurred on Wednesday, April 3rd. The stock was sold at an average price of $9.46, for a total value of $690,532.70. Following the sale, the chief executive officer now directly owns 678,457 […]